Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial-Reference-Cited by-同舟云学术

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial

Published:2000-09 Issue:9234 Volume:356 Page:961-967
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Levin Michael,Quint Peter A,Goldstein Brahm,Barton Phil,Bradley John S,Shemie SD,Yeh Timothy,Kim Sun Sook,Cafaro Daniel P,Scannon Patrick J,Giroir Brett P

Publisher

Elsevier BV

Subject

General Medicine

Reference30 articles.

1. Epidemiology of meningococcal disease in Europe and the the USA;Jones,1995

2. Pathophysiology and management of meningococcal disease septicaemia;Heyderman,1993

3. Treatment of meningococcal disease in childhood;Nadel,1995

4. Pathogenesis of meningococcal infections;Brandtzaeg,1995

5. The European Pediatric Meningococcal Septic Shock Trial Study Group. Randomized, placebo-controlled trial of HA-1A, a human monoclonal antibody to endotoxin, in children with meningococcal septic shock;Derkx;Clin Infect Dis,1999

Cited by 373 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in the context of sepsis-induced immunological dysregulation;Frontiers in Immunology;2024-05-21

2. Recent advances in blood toxin removal technology;Sustainable Materials and Technologies;2024-04

3. BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function;International Journal of Antimicrobial Agents;2024-01

4. Meningococcal Diseases in Travellers;Emerging and Re-emerging Infections in Travellers;2024

5. The dangerous liaisons in innate immunity involving recombinant proteins and endotoxins: Examples from the literature and the Leptospira field;Journal of Biological Chemistry;2024-01